C Partners Holding Gmb H Repligen Corp Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$48.26 - $68.88 $120,119 - $171,442	-2,489 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $160,336 - $202,031	-3,426 Reduced 57.92%	2,489 $138,000
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $13,504 - $18,016	-383 Reduced 6.08%	5,915 $278,000
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $23,375 - $28,176	-756 Reduced 10.72%	6,298 $228,000
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $229,466 - $274,541	7,054	7,054 $256,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.85B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.